Month: <span>October 2021</span>

Home / 2021 / October
Revealing the logic of the body’s ‘second brain’
Post

Revealing the logic of the body’s ‘second brain’

by Matt Davenport,  Michigan State University A network of glial cells, the logic gates of the gut’s nervous system, are seen in this micrograph. The cells — the dark orbs enveloped in gray — have been colorized according to how they respond to a chemical signal. Credit: Proc. Natl. Acad. Sci./Gulbransen Lab Researchers at Michigan State University...

Cannabis users at ‘much higher’ risk of developing mental health issues
Post

Cannabis users at ‘much higher’ risk of developing mental health issues

by  University of Birmingham Credit: Unsplash/CC0 Public Domain Those with a recorded history of cannabis use in general practice records are at a much higher risk of developing mental ill health problems such as anxiety or depression as well as severe mental illnesses, new research shows. The findings point to the need for a public health approach to...

A single gene can disrupt the sleep-wake cycle
Post

A single gene can disrupt the sleep-wake cycle

by  University of Geneva Neurons in drosophila brain marked with green fluorescent protein. The most colored parts highlight the mushroom bodies, a key center for sleep regulation. Credit: UNIGE All living organisms are subject to an internal biological rhythm, which controls many physiological processes. In humans in particular, this internal clock follows a 24-hour cycle and...

New ‘almanac’ may help clinicians better tailor cancer treatments
Post

New ‘almanac’ may help clinicians better tailor cancer treatments

by Allessandra Dicorato,  Broad Institute of MIT and Harvard A microscope image of squamous cell carcinoma, a common kind of skin cancer. Credit: Markus Schober and Elaine Fuchs, The Rockefeller University Researchers have developed a tool that integrates a variety of molecular data from patients and tumors, with the goal of guiding precision medicine. A promise of...

Merck’s Covid pill hailed after cutting hospitalizations by 50%
Post

Merck’s Covid pill hailed after cutting hospitalizations by 50%

Capsules of the experimental antiviral drug Molnupiravir. Pharmaceutical company Merck said Friday it will seek authorization in the US of its oral drug molnupiravir for COVID-19 after it was shown to reduce the chance newly infected patients were hospitalized by 50 percent. A simple pill to treat the coronavirus has been sought since the start...

Blood marker could help ID those at risk of debilitating peripheral artery disease
Post

Blood marker could help ID those at risk of debilitating peripheral artery disease

by Julia Evangelou Strait,  Washington University School of Medicine A cross section of a peripheral artery from the leg of a patient with chronic limb-threatening ischemia, a condition in which heavy plaque formation causes a severe narrowing of the arteries. A new study from Washington University School of Medicine in St. Louis has identified a key...